2017 Press Releases

Webcast ImageWebcast
Kindred Biosciences' Third Quarter 2017 Financial Results  (Live)
11/07/17 at 4:30 p.m. ET
Kindred Biosciences' Third Quarter 2017 Financial Results
Tuesday, November 7, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013

Kindred Biosciences to Announce Third Quarter 2017 Financial Results

October 11, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference

October 5, 2017

SAN FRANCISCO, Oct. 5, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof

September 11, 2017

SAN FRANCISCO, Sept. 11, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Present at Upcoming Investor Conferences

August 30, 2017

SAN FRANCISCO, Aug. 30, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Second Quarter 2017 Financial Results

August 7, 2017

SAN FRANCISCO, Aug. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting

August 4, 2017

SAN FRANCISCO, Aug. 4, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Second Quarter 2017 Financial Results

July 24, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

KindredBio Announces Pricing of Public Offering

July 12, 2017

SAN FRANCISCO, July 12, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

KindredBio Announces Proposed Public Offering of Common Stock

July 11, 2017

SAN FRANCISCO, July 11, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Acquisition of Kansas Manufacturing Plant and Execution of Commercial Manufacturing Agreement for Zimeta

June 26, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Added to the Russell 2000 Index

June 15, 2017

SAN FRANCISCO, June 15, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences to Present Data from Six Studies at the 2017 American College of Veterinary Internal Medicine Conference

May 30, 2017

SAN FRANCISCO, May 30, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Present at 7th Annual LD Micro Invitational

May 24, 2017

SAN FRANCISCO, May 24, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces First Quarter 2017 Financial Results

May 3, 2017

SAN FRANCISCO, May 3, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI... 

Kindred Biosciences Announces Initiation of Enrollment in Pivotal Effectiveness Trial of Zimeta Oral for the Control of Fever in Horses

May 1, 2017

SAN FRANCISCO, May 1, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI... 

Kindred Biosciences to Announce First Quarter 2017 Financial Results

April 24, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Present at 2017 Jefferies Animal Health Summit

March 16, 2017

SAN FRANCISCO, March 16, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology

March 7, 2017

SAN FRANCISCO, March 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Fourth Quarter and Year-End 2016 Financial Results

March 1, 2017

SAN FRANCISCO, March 1, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Biosciences to Announce Fourth Quarter and Year-End 2016 Financial Results

February 21, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Receives Early Approval of Effectiveness Technical Section from FDA for Mirataz™ New Animal Drug Application

February 6, 2017

SAN FRANCISCO, Feb. 6, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...